Publications

 

1) Marina RJ, Sturgill D, Bailly MA, Thenoz M, Varma G, Prigge MF, Nanan KK, Shukla S, Haque N, Oberdoerffer S.TET-catalyzed oxidation of intragenic 5-methylcytosine regulates CTCF-dependent alternative splicing. EMBO J. 2015 Dec 28. pii: e201593235. [Epub ahead of print]

 

2)Narayanan SP, Singh S, Gupta A, Yadav S, Singh SR, Shukla S. Integrated genomic analyses identify KDM1A's role in cell proliferation via modulating E2F signaling activity and associate with poor clinical outcome in oral cancer. Cancer Letters 367 (2015) 162–172.

 

3) Pranay A, Shukla S et al.  Prognostic utility of autoantibodies to α-enolase and Hsp70 for cancer of the gingivo-buccal complex using immunoproteomics. Proteomics Clinical Applications 2013; June;7(5-6):392-402.

 

4) Shukla S., Oberdoerffer S. Co-transcriptional regulation of alternative pre-mRNA splicing. BBA-Gene Regulatory Mechanism July 2012, 1819 (7), 673-683.

 

5) Shukla S, Kavak E, Gregory M, Imashimizu M, Shutinoski B, Kashlev M, Oberdoerffer P, Sandberg R,    Oberdoerffer S. “CTCF-promoted RNA polymerase II pausing links DNA methylation to splicing”.    Nature 479, 74–79 (03 November 2011).

 

This article was highlighted in Cell Research- Kornblihtt A. “CTCF: from insulators to alternative splicing regulation”, Cell Research advance online publication 7 February 2012; doi:10.1038/cr.2012.22

http://www.nature.com/cr/journal/vaop/ncurrent/full/cr201222a.html

 

This article was also highlighted in CCR connections Vol 6 (1), 2012 “CTCF, a Novel Regulator of Alternative Splicing” http://home.ccr.cancer.gov/connections/dev/2012/Vol6_No1/news_7.asp

 

Received F1000 article factor (FFa) -17 (exceptional rating) from Faculty of 1000 based on following 4 evaluations. http://f1000.com/13371987

 

6)Shukla S, Pranay A, D’Cruz AK, Chaturvedi P, Kane SV, Zingde SM “Immunoproteomics reveals that cancer of the tongue and the gingivo buccal complex exhibit differential autoantibody response.” Cancer Biomarkers 2009, 5(3): 127-35.

 

7)Shukla S, Govekar RB, Sirdeshmukh R, Sundaram CS, D’Cruz A, Pathak KA, Kane SV, Zingde SM Tumor antigens eliciting autoantibody response in cancer of gingivo-buccal complex. Proteomics Clinical Applications 2007, 1(12): 1592-1604.

 

Patent

 

Zingde, Shukla, Sirdeshmukh, Sundaram D’Cruz, Pathak, Kane [Inventors] Autoantibodies for protein antigens as markers for cancer of the ginigivo –buccal complex:

US Patent granted: US 8492100 B2

CSIR: Ref No: 0187NF 2006/1N, filed on Feb 14, 2007; 290DEL 2007

European Patent Application EP2126578 (Published: Feb 12, 2009)